THG

SEC source: 0001062993-25-008896 · form4.xml · nonDerivative · entry 3

Salvatore Bryan J · CIK 0001709075 · Executive Vice President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,977.588

F1 · kind: Exercise of options scheduled to expire in June 2027 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 27, 2024.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold at multiple prices ranging from $166.63 to $167.56. The Reporting Person undertakes to provide THG, any security holder of THG, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

SEC source: 0001062993-25-008896 · form4.xml · nonDerivative · entry 2

Salvatore Bryan J · CIK 0001709075 · Executive Vice President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 31,414.588

F1 · kind: Exercise of options scheduled to expire in June 2027 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 27, 2024.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold at multiple prices ranging from $165.60 to $166.59. The Reporting Person undertakes to provide The Hanover Insurance Group, Inc. ("THG"), any security holder of THG, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

SEC source: 0001062993-25-008896 · form4.xml · nonDerivative · entry 1

Salvatore Bryan J · CIK 0001709075 · Executive Vice President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 36,389.588

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Exercise of options scheduled to expire in June 2027 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 27, 2024.

SEC source: 0001062993-25-006823 · form4.xml · derivative · entry 3

Roche John C · CIK 0001428157 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,906 shares

Expires 2026-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Exercise of options scheduled to expire in February 2026 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024.

F4 · derivative.exercise_date: The option, representing the right to purchase a total of 21,413 shares, vested 1/3 on each of 2/23/17, 2/23/18 and 2/23/19.

SEC source: 0001062993-25-006823 · form4.xml · nonDerivative · entry 2

Roche John C · CIK 0001428157 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 124,413.708

F1 · kind: Exercise of options scheduled to expire in February 2026 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold at multiple prices ranging from $175 to $175.83. The Reporting Person undertakes to provide The Hanover Insurance Group, Inc. ("THG"), any security holder of THG, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse.

SEC source: 0001062993-25-006823 · form4.xml · nonDerivative · entry 1

Roche John C · CIK 0001428157 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 133,319.708

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Exercise of options scheduled to expire in February 2026 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024.

F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse.

SEC source: 0001062993-25-006637 · form4.xml · derivative · entry 7

Roche John C · CIK 0001428157 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,906

Underlying: Common Stock · 301 shares

Expires 2026-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Exercise of options scheduled to expire in February 2026 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024.

F4 · derivative.exercise_date: The option, representing the right to purchase a total of 21,413 shares, vested 1/3 on each of 2/23/17, 2/23/18 and 2/23/19.

SEC source: 0001062993-25-006637 · form4.xml · nonDerivative · entry 5

Roche John C · CIK 0001428157 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 124,413.708

F1 · kind: Exercise of options scheduled to expire in February 2026 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024.

F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse.

SEC source: 0001062993-25-006637 · form4.xml · nonDerivative · entry 4

Roche John C · CIK 0001428157 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 124,714.708

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Exercise of options scheduled to expire in February 2026 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024.

F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse.

SEC source: 0001062993-25-006643 · form4.xml · nonDerivative · entry 1

Lowsley Denise · CIK 0001572984 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,033.816

F1 · kind: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Long-Term Incentive Plan ("2022 LTIP") in connection with the accrual of dividend equivalent rights associated with RSUs previously granted under the Issuer's 2022 LTIP. Such RSUs vest on the third anniversary of the date of grant of the original underlying RSUs.

SEC source: 0001062993-25-006644 · form4.xml · nonDerivative · entry 1

LOVELY DAVID JOHN · CIK 0001958694 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,254.138

F1 · kind: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Long-Term Incentive Plan ("2022 LTIP") in connection with the accrual of dividend equivalent rights associated with RSUs previously granted under the Issuer's 2022 LTIP. Such RSUs vest on the third anniversary of the date of grant of the original underlying RSUs.

SEC source: 0001062993-25-006642 · form4.xml · nonDerivative · entry 1

FARBER JEFFREY M · CIK 0001275634 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,890.702

F1 · kind: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Long-Term Incentive Plan ("2022 LTIP") in connection with the accrual of dividend equivalent rights associated with RSUs previously granted under the Issuer's 2022 LTIP. Such RSUs vest on the third anniversary of the date of grant of the original underlying RSUs.

SEC source: 0001062993-25-006641 · form4.xml · nonDerivative · entry 1

Lee Willard T · CIK 0001843620 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,455.217

F1 · kind: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Long-Term Incentive Plan ("2022 LTIP") in connection with the accrual of dividend equivalent rights associated with RSUs previously granted under the Issuer's 2022 LTIP. Such RSUs vest on the third anniversary of the date of grant of the original underlying RSUs.

SEC source: 0001062993-25-006640 · form4.xml · nonDerivative · entry 1

LAVEY RICHARD W · CIK 0001275977 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,079.14

F1 · kind: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Long-Term Incentive Plan ("2022 LTIP") in connection with the accrual of dividend equivalent rights associated with RSUs previously granted under the Issuer's 2022 LTIP. Such RSUs vest on the third anniversary of the date of grant of the original underlying RSUs.

SEC source: 0001062993-25-006639 · form4.xml · nonDerivative · entry 1

Kerrigan Dennis Francis · CIK 0001799888 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,995.588

F1 · kind: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Long-Term Incentive Plan ("2022 LTIP") in connection with the accrual of dividend equivalent rights associated with RSUs previously granted under the Issuer's 2022 LTIP. Such RSUs vest on the third anniversary of the date of grant of the original underlying RSUs.

SEC source: 0001062993-25-006638 · form4.xml · nonDerivative · entry 1

Salvatore Bryan J · CIK 0001709075 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,863.588

F1 · kind: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Long-Term Incentive Plan ("2022 LTIP") in connection with the accrual of dividend equivalent rights associated with RSUs previously granted under the Issuer's 2022 LTIP. Such RSUs vest on the third anniversary of the date of grant of the original underlying RSUs.

SEC source: 0001062993-25-006637 · form4.xml · derivative · entry 6

Roche John C · CIK 0001428157 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,207

Underlying: Common Stock · 400 shares

Expires 2026-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Exercise of options scheduled to expire in February 2026 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024.

F4 · derivative.exercise_date: The option, representing the right to purchase a total of 21,413 shares, vested 1/3 on each of 2/23/17, 2/23/18 and 2/23/19.

SEC source: 0001062993-25-006637 · form4.xml · nonDerivative · entry 3

Roche John C · CIK 0001428157 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 124,413.708

F3 · kind: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Long-Term Incentive Plan ("2022 LTIP") in connection with the accrual of dividend equivalent rights associated with RSUs previously granted under the Issuer's 2022 LTIP. Such RSUs vest on the third anniversary of the date of grant of the original underlying RSUs.

F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse.

SEC source: 0001062993-25-006637 · form4.xml · nonDerivative · entry 2

Roche John C · CIK 0001428157 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 124,277.851

F1 · kind: Exercise of options scheduled to expire in February 2026 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024.

F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse.

SEC source: 0001062993-25-006637 · form4.xml · nonDerivative · entry 1

Roche John C · CIK 0001428157 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 124,677.851

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Exercise of options scheduled to expire in February 2026 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024.

F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse.

SEC source: 0001062993-25-006497 · form4.xml · derivative · entry 6

Roche John C · CIK 0001428157 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,607

Underlying: Common Stock · 200 shares

Expires 2026-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Exercise of options scheduled to expire in February 2026 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024.

F5 · derivative.exercise_date: The option, representing the right to purchase a total of 21,413 shares, vested 1/3 on each of 2/23/17, 2/23/18 and 2/23/19.

SEC source: 0001062993-25-006497 · form4.xml · nonDerivative · entry 4

Roche John C · CIK 0001428157 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 124,277.851

F1 · kind: Exercise of options scheduled to expire in February 2026 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold at multiple prices ranging from $175 to $175.01. The Reporting Person undertakes to provide THG, any security holder of THG, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse.

SEC source: 0001062993-25-006497 · form4.xml · nonDerivative · entry 3

Roche John C · CIK 0001428157 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 124,477.851

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Exercise of options scheduled to expire in February 2026 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024.

F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse.

SEC source: 0001062993-25-006497 · form4.xml · derivative · entry 5

Roche John C · CIK 0001428157 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,807

Underlying: Common Stock · 900 shares

Expires 2026-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Exercise of options scheduled to expire in February 2026 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024.

F5 · derivative.exercise_date: The option, representing the right to purchase a total of 21,413 shares, vested 1/3 on each of 2/23/17, 2/23/18 and 2/23/19.

SEC source: 0001062993-25-006497 · form4.xml · nonDerivative · entry 2

Roche John C · CIK 0001428157 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 124,277.851

F1 · kind: Exercise of options scheduled to expire in February 2026 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold at multiple prices ranging from $175 to $175.27. The Reporting Person undertakes to provide The Hanover Insurance Group, Inc. ("THG"), any security holder of THG, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse.

SEC source: 0001062993-25-006497 · form4.xml · nonDerivative · entry 1

Roche John C · CIK 0001428157 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 125,177.851

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Exercise of options scheduled to expire in February 2026 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024.

F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse.

SEC source: 0001062993-25-004322 · form4.xml · derivative · entry 5

Salvatore Bryan J · CIK 0001709075 · Executive Vice President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,526

Underlying: Common Stock · 10,526 shares

Expires 2027-06-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Exercise of options scheduled to expire in June 2027 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 27, 2024.

F5 · derivative.exercise_date: The option, representing the right to purchase a total of 21,052 shares, vested 1/3 on each of 6/12/2018, 6/12/2019 and 6/12/2020.

SEC source: 0001062993-25-004322 · form4.xml · nonDerivative · entry 4

Salvatore Bryan J · CIK 0001709075 · Executive Vice President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,835.537

F1 · kind: Exercise of options scheduled to expire in June 2027 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 27, 2024.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold at multiple prices ranging from $172.36 to $173.12. The Reporting Person undertakes to provide THG, any security holder of THG, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

SEC source: 0001062993-25-004322 · form4.xml · nonDerivative · entry 3

Salvatore Bryan J · CIK 0001709075 · Executive Vice President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30,869.537

F1 · kind: Exercise of options scheduled to expire in June 2027 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 27, 2024.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold at multiple prices ranging from $171.35 to $172.35. The Reporting Person undertakes to provide THG, any security holder of THG, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

SEC source: 0001062993-25-004322 · form4.xml · nonDerivative · entry 2

Salvatore Bryan J · CIK 0001709075 · Executive Vice President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 34,861.537

F1 · kind: Exercise of options scheduled to expire in June 2027 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 27, 2024.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold at multiple prices ranging from $170.33 to $171.33. The Reporting Person undertakes to provide The Hanover Insurance Group, Inc. ("THG"), any security holder of THG, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

SEC source: 0001062993-25-004322 · form4.xml · nonDerivative · entry 1

Salvatore Bryan J · CIK 0001709075 · Executive Vice President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 36,361.537

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Exercise of options scheduled to expire in June 2027 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 27, 2024.

SEC source: 0001062993-25-004321 · form4.xml · derivative · entry 5

Roche John C · CIK 0001428157 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,707

Underlying: Common Stock · 10,706 shares

Expires 2026-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Exercise of options scheduled to expire in February 2025 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024.

F6 · derivative.exercise_date: The option, representing the right to purchase a total of 21,413 shares, vested 1/3 on each of 2/23/17, 2/23/18 and 2/23/19.

SEC source: 0001062993-25-004321 · form4.xml · nonDerivative · entry 4

Roche John C · CIK 0001428157 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 124,277.851

F1 · kind: Exercise of options scheduled to expire in February 2025 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024.

F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold at multiple prices ranging from $172.35 to $173.31. The Reporting Person undertakes to provide THG, any security holder of THG, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse.

SEC source: 0001062993-25-004321 · form4.xml · nonDerivative · entry 3

Roche John C · CIK 0001428157 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 129,786.851

F1 · kind: Exercise of options scheduled to expire in February 2025 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold at multiple prices ranging from $171.34 to $172.34. The Reporting Person undertakes to provide THG, any security holder of THG, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse.

SEC source: 0001062993-25-004321 · form4.xml · nonDerivative · entry 2

Roche John C · CIK 0001428157 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 133,089.851

F1 · kind: Exercise of options scheduled to expire in February 2025 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold at multiple prices ranging from $170.33 to $171.33. The Reporting Person undertakes to provide The Hanover Insurance Group, Inc. ("THG"), any security holder of THG, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse.

SEC source: 0001062993-25-004321 · form4.xml · nonDerivative · entry 1

Roche John C · CIK 0001428157 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 134,983.851

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Exercise of options scheduled to expire in February 2025 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024.

F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse.

SEC source: 0001062993-25-004107 · form4.xml · nonDerivative · entry 1

Lowsley Denise · CIK 0001572984 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,022.028

F1 · kind: Represents shares that were forfeited to pay withholding taxes upon the vesting of restricted stock units that were previously granted by the Issuer and vested on February 28, 2025. In connection with vesting, any fractional shares were rounded up to the next whole share in accordance with the terms of the award agreement.

SEC source: 0001062993-25-004106 · form4.xml · nonDerivative · entry 3

Roche John C · CIK 0001428157 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,277.851

F3 · kind: Represents shares that were forfeited to pay withholding taxes upon the vesting of restricted stock units that were previously granted by the Issuer and vested on February 28, 2025. In connection with vesting, any fractional shares were rounded up to the next whole share in accordance with the terms of the award agreement.

F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse.

SEC source: 0001062993-25-004104 · form4.xml · nonDerivative · entry 1

FARBER JEFFREY M · CIK 0001275634 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,840.529

F1 · kind: Represents shares that were forfeited to pay withholding taxes upon the vesting of restricted stock units that were previously granted by the Issuer and vested on February 28, 2025. In connection with vesting, any fractional shares were rounded up to the next whole share in accordance with the terms of the award agreement.

SEC source: 0001062993-25-004103 · form4.xml · nonDerivative · entry 1

Lee Willard T · CIK 0001843620 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,443.028

F1 · kind: Represents shares that were forfeited to pay withholding taxes upon the vesting of restricted stock units that were previously granted by the Issuer and vested on February 28, 2025. In connection with vesting, any fractional shares were rounded up to the next whole share in accordance with the terms of the award agreement.

SEC source: 0001062993-25-004102 · form4.xml · nonDerivative · entry 1

Salvatore Bryan J · CIK 0001709075 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,835.537

F1 · kind: Represents shares that were forfeited to pay withholding taxes upon the vesting of restricted stock units that were previously granted by the Issuer and vested on February 28, 2025. In connection with vesting, any fractional shares were rounded up to the next whole share in accordance with the terms of the award agreement.

SEC source: 0001062993-25-004099 · form4.xml · nonDerivative · entry 1

Kerrigan Dennis Francis · CIK 0001799888 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,977.589

F1 · kind: Represents shares that were forfeited to pay withholding taxes upon the vesting of restricted stock units that were previously granted by the Issuer and vested on February 28, 2025. In connection with vesting, any fractional shares were rounded up to the next whole share in accordance with the terms of the award agreement.

SEC source: 0001062993-25-004101 · form4.xml · nonDerivative · entry 1

LAVEY RICHARD W · CIK 0001275977 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,047.704

F1 · kind: Represents shares that were forfeited to pay withholding taxes upon the vesting of restricted stock units that were previously granted by the Issuer and vested on February 28, 2025. In connection with vesting, any fractional shares were rounded up to the next whole share in accordance with the terms of the award agreement.

SEC source: 0001062993-25-004106 · form4.xml · derivative · entry 4

Roche John C · CIK 0001428157 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 22,943 shares

Expires 2025-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Pursuant to the terms of his 2/27/15 Option Agreement (the "Agreement"), in-the-money options held by Mr. Roche immediately prior to expiration of the option are automatically "net exercised". Accordingly, per the terms of the Agreement such options were "net exercised" on 2/27/25. To that end a total of 15,604 shares were withheld by the Company to satisfy the exercise price and taxes associated with the exercise, resulting in a net issuance of 7,339 shares to, and held by, Mr. Roche.

F4 · derivative.exercise_date: The option vested 1/3 on each of 02/27/16, 02/27/17 and 02/27/18.

SEC source: 0001062993-25-004106 · form4.xml · nonDerivative · entry 2

Roche John C · CIK 0001428157 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,103.333

F1 · kind: Pursuant to the terms of his 2/27/15 Option Agreement (the "Agreement"), in-the-money options held by Mr. Roche immediately prior to expiration of the option are automatically "net exercised". Accordingly, per the terms of the Agreement such options were "net exercised" on 2/27/25. To that end a total of 15,604 shares were withheld by the Company to satisfy the exercise price and taxes associated with the exercise, resulting in a net issuance of 7,339 shares to, and held by, Mr. Roche.

F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse.

SEC source: 0001062993-25-004106 · form4.xml · nonDerivative · entry 1

Roche John C · CIK 0001428157 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 148,707.333

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Pursuant to the terms of his 2/27/15 Option Agreement (the "Agreement"), in-the-money options held by Mr. Roche immediately prior to expiration of the option are automatically "net exercised". Accordingly, per the terms of the Agreement such options were "net exercised" on 2/27/25. To that end a total of 15,604 shares were withheld by the Company to satisfy the exercise price and taxes associated with the exercise, resulting in a net issuance of 7,339 shares to, and held by, Mr. Roche.

F2 · balance_after: Does not include 14,454 shares held by the Reporting Person's spouse.

SEC source: 0001062993-25-003671 · form4.xml · derivative · entry 4

Lee Willard T · CIK 0001843620 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,539

Underlying: Common Stock · 3,539 shares

Expires 2035-02-25

F4 · derivative.exercise_date: Such options vest as to one-third of the shares on each of the first three anniversaries of the grant date.

SEC source: 0001062993-25-003671 · form4.xml · nonDerivative · entry 3

Lee Willard T · CIK 0001843620 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,212.324

F3 · kind: Grant of restricted stock units under the Issuer's 2022 Long-Term Incentive Plan. Such units vest on the third anniversary of the date of grant.

SEC source: 0001062993-25-003669 · form4.xml · derivative · entry 4

LAVEY RICHARD W · CIK 0001275977 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,377

Underlying: Common Stock · 9,377 shares

Expires 2035-02-25

F4 · derivative.exercise_date: Such options vest as to one-third of the shares on each of the first three anniversaries of the grant date.

SEC source: 0001062993-25-003669 · form4.xml · nonDerivative · entry 3

LAVEY RICHARD W · CIK 0001275977 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,963.752

F3 · kind: Grant of restricted stock units under the Issuer's 2022 Long-Term Incentive Plan. Such units vest on the third anniversary of the date of grant.